World neurosurgery · 2026
Low Molecular Weight Heparin Initiated 3 Hours After Venous Sinus Stenting May Reduce Bleeding Risk in Patients with Cerebral Venous Sinus Stenosis.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Han Guangyu, Zhou Da, Huang Xiangqian, Wan Shuling, Wang Mengqi, Ji Xunming, Meng Ran
Аннотация
OBJECTIVE: This study aimed to assess whether the timing of low molecular weight heparin (LMWH) initiation after venous sinus stenting affects early hemorrhagic risk in patients with cerebral venous sinus stenosis (CVSS).
METHODS: This single-center, real-world study consecutively enrolled CVSS patients at the subacute or chronic stage who underwent venous sinus stenting from January 2017 to July 2023. Based on the timing of LMWH initiation, patients were categorized into 2 groups: the immediate poststenting group and the third-hour poststenting group. Clinical characteristics, coagulation parameters, computed tomography imaging, and available follow-up data were compared.
RESULTS: A total of 105 eligible patients (median age 37.0 years; 75 females and 30 males) were included in the analysis. Among them, 46 patients received immediate LMWH initiation, while 59 received LMWH 3 hours poststenting. Across all patients, postoperative coagulation parameters [e.g., activated partial thromboplastin time, prothrombin time, thrombin time, fibrinogen] changed significantly compared with baseline (all P < 0.001). Notably, activated partial thromboplastin time at 3 hours poststenting was significantly lower in the third-hour group than in the immediate group [73.20 (67.40-81.30) s versus 84.35 (80.13-93.23) s, P < 0.001]. The immediate group had a higher incidence of symptomatic intracranial hemorrhage than the third-hour group (8.7% vs. 0.0%, P = 0.034). During follow-up, no stent-related stenosis, restenosis, or delayed bleeding were observed in either group.
CONCLUSIONS: Delaying LMWH anticoagulation until 3 hours poststenting may effectively reduce bleeding risk in CVSS patients. These findings support optimizing early postoperative anticoagulation timing to enhance procedural safety and warrant validation in prospective studies.
METHODS: This single-center, real-world study consecutively enrolled CVSS patients at the subacute or chronic stage who underwent venous sinus stenting from January 2017 to July 2023. Based on the timing of LMWH initiation, patients were categorized into 2 groups: the immediate poststenting group and the third-hour poststenting group. Clinical characteristics, coagulation parameters, computed tomography imaging, and available follow-up data were compared.
RESULTS: A total of 105 eligible patients (median age 37.0 years; 75 females and 30 males) were included in the analysis. Among them, 46 patients received immediate LMWH initiation, while 59 received LMWH 3 hours poststenting. Across all patients, postoperative coagulation parameters [e.g., activated partial thromboplastin time, prothrombin time, thrombin time, fibrinogen] changed significantly compared with baseline (all P < 0.001). Notably, activated partial thromboplastin time at 3 hours poststenting was significantly lower in the third-hour group than in the immediate group [73.20 (67.40-81.30) s versus 84.35 (80.13-93.23) s, P < 0.001]. The immediate group had a higher incidence of symptomatic intracranial hemorrhage than the third-hour group (8.7% vs. 0.0%, P = 0.034). During follow-up, no stent-related stenosis, restenosis, or delayed bleeding were observed in either group.
CONCLUSIONS: Delaying LMWH anticoagulation until 3 hours poststenting may effectively reduce bleeding risk in CVSS patients. These findings support optimizing early postoperative anticoagulation timing to enhance procedural safety and warrant validation in prospective studies.